Little Green Pharma Statistics

Total Valuation

Little Green Pharma has a market cap or net worth of AUD 40.89 million. The enterprise value is 40.89 million.

Market Cap	40.89M
Enterprise Value	40.89M

Important Dates

The last earnings date was Tuesday, November 26, 2024.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	n/a

Share Statistics

Little Green Pharma has 302.87 million shares outstanding. The number of shares has increased by 7.78% in one year.

Current Share Class	n/a
Shares Outstanding	302.87M
Shares Change (YoY)	+7.78%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	16.15%
Owned by Institutions (%)	21.26%
Float	194.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.41
PB Ratio	0.56
P/TBV Ratio	0.57
P/FCF Ratio	20.47
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.34
EV / Sales	1.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	20.47

Financial Position

The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.07.

Current Ratio	2.64
Quick Ratio	0.89
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	2.42
Interest Coverage	-15.69

Financial Efficiency

Return on equity (ROE) is -12.31% and return on invested capital (ROIC) is -6.47%.

Return on Equity (ROE)	-12.31%
Return on Assets (ROA)	-6.03%
Return on Capital (ROIC)	-6.47%
Revenue Per Employee	307,232
Profits Per Employee	-100,325
Employee Count	94
Asset Turnover	0.33
Inventory Turnover	1.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.85% in the last 52 weeks. The beta is 1.27, so Little Green Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	+3.85%
50-Day Moving Average	0.13
200-Day Moving Average	0.11
Relative Strength Index (RSI)	56.51
Average Volume (20 Days)	135,807

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Little Green Pharma had revenue of AUD 28.88 million and -9.43 million in losses. Loss per share was -0.03.

Revenue	28.88M
Gross Profit	12.79M
Operating Income	-8.48M
Pretax Income	-9.43M
Net Income	-9.43M
EBITDA	-5.84M
EBIT	-8.48M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 4.83 million in cash and 4.84 million in debt, giving a net cash position of -7,000 or -0.00 per share.

Cash & Cash Equivalents	4.83M
Total Debt	4.84M
Net Cash	-7,000
Net Cash Per Share	-0.00
Equity (Book Value)	72.58M
Book Value Per Share	0.24
Working Capital	13.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.62 million and capital expenditures -627,360, giving a free cash flow of 2.00 million.

Operating Cash Flow	2.62M
Capital Expenditures	-627,360
Free Cash Flow	2.00M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 44.27%, with operating and profit margins of -29.37% and -32.65%.

Gross Margin	44.27%
Operating Margin	-29.37%
Pretax Margin	-32.65%
Profit Margin	-32.65%
EBITDA Margin	-20.24%
EBIT Margin	-29.37%
FCF Margin	6.92%

Dividends & Yields

Little Green Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.78%
Shareholder Yield	-7.78%
Earnings Yield	-23.24%
FCF Yield	4.89%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Little Green Pharma has an Altman Z-Score of 1.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.73
Piotroski F-Score	n/a